NCT05546255 2022-09-19
Eribulin Mesylate Combined With Lobaplatin in the Treatment of Recurrent or Metastatic Triple-negative Breast Cancer
ChineseAMS
Phase 2 Unknown
Clinical Trials
7 trialsNCT04745975 2022-04-20
Guided Treatment Based on Mini-PDX in Metastatic Triple Negative Breast Cancer
Fudan University
Phase 2 Unknown
NCT04913571 2021-06-04
TEMPLATE
Fudan University
Phase 2 Unknown
NCT04517292 2020-08-18
GEP
Fudan University
Phase 2 Unknown
NCT04502680 2020-08-11
EMBRAVE-001
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01372579 2019-06-07
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients
Northwestern University
Phase 2 Unknown
NCT02616848 2015-11-30
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Istituti Ospitalieri di Cremona
Phase 1 Unknown